Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
Adam R Brentnall
Affiliation
Queen Mary Universityof London
ORCID
Career Start Year
2010
Papers
78
H Index
27
Expertise
CM4AI Collaborator
PMID
Paper Title
Journal Title
Published Year
38065518
Staged design recommendations for validating relative sensitivity of self-sample human papillomavirus tests for cervical screening.
J Clin Epidemiol
2024
38070530
Effect of baseline oestradiol serum concentration on the efficacy of anastrozole for preventing breast cancer in postmenopausal women at high risk: a case-control study of the IBIS-II prevention trial.
Lancet Oncol
2024
36635680
Obesity at age 20 and weight gain during adulthood increase risk of total and premature all-cause mortality: findings from women attending breast screening in Manchester.
BMC Womens Health
2023
38017184
An optimization framework to guide the choice of thresholds for risk-based cancer screening.
NPJ Digit Med
2023
38001476
Development and evaluation of a method to assess breast cancer risk using a longitudinal history of mammographic density: a cohort study.
Breast Cancer Res
2023
37650883
Breast cancer polygenic risk scores derived in White European populations are not calibrated for women of Ashkenazi Jewish descent.
Genet Med
2023
37061873
Breast cancer polygenic risk scores derived in White European populations are not calibrated for women of Ashkenazi Jewish descent.
Genet Med
2023
37059410
Quality of life after risk-reducing surgery for breast and ovarian cancer prevention: a systematic review and meta-analysis.
Am J Obstet Gynecol
2023
37310244
Evaluation of an AI Model to Assess Future Breast Cancer Risk.
Radiology
2023
37470832
Safety and efficacy of artesunate treatment in severely injured patients with traumatic hemorrhage. The TOP-ART randomized clinical trial.
Intensive Care Med
2023
37005486
Quantifying the effects of risk-stratified breast cancer screening when delivered in real time as routine practice versus usual screening: the BC-Predict non-randomised controlled study (NCT04359420).
Br J Cancer
2023
37095697
Dynamic data-enabled stratified sampling for trial invitations with application in NHS-Galleri.
Clin Trials
2023
37095186
Correction To: Quantifying the effects of risk-stratified breast cancer screening when delivered in real time as routine practice versus usual screening: the BC-Predict non-randomised controlled study (NCT04359420).
Br J Cancer
2023
36749434
Variability Among Breast Cancer Risk Classification Models When Applied at the Level of the Individual Woman.
J Gen Intern Med
2023
36831615
Impact of Multiple COVID-19 Waves on Gynaecological Cancer Services in the UK.
Cancers (Basel)
2023
34460111
The importance of ethnicity: Are breast cancer polygenic risk scores ready for women who are not of White European origin?
Int J Cancer
2022
35377465
Comments on: "Meta-analysis of agreement/concordance statistics in studies comparing self- vs clinician-collected samples for HPV testing in cervical cancer screening".
Int J Cancer
2022
35426792
Breast cancer risk stratification in women of screening age: Incremental effects of adding mammographic density, polygenic risk, and a gene panel.
Genet Med
2022
36434583
Supporting the implementation of new healthcare technologies by investigating generalisability of pilot studies using area-level statistics.
BMC Health Serv Res
2022
36223373
Using ISARIC 4C mortality score to predict dynamic changes in mortality risk in COVID-19 patients during hospital admission.
PLoS One
2022
33006394
Effective methylation triage of HPV positive women with abnormal cytology in a middle-income country.
Int J Cancer
2021
34697802
Mammographic density, endocrine therapy and breast cancer risk: a prognostic and predictive biomarker review.
Cochrane Database Syst Rev
2021
34072619
Is Breast Cancer Risk Associated with Menopausal Hormone Therapy Modified by Current or Early Adulthood BMI or Age of First Pregnancy?
Cancers (Basel)
2021
34209579
The Relationship between Body Mass Index and Mammographic Density during a Premenopausal Weight Loss Intervention Study.
Cancers (Basel)
2021
33977903
The Barts Health NHS Trust COVID-19 cohort: characteristics, outcomes and risk scoring of patients in East London.
Int J Tuberc Lung Dis
2021
32194845
Integrin αvβ6-specific therapy for pancreatic cancer developed from foot-and-mouth-disease virus.
Theranostics
2020
32037401
Errors in determination of net survival: cause-specific and relative survival settings.
Br J Cancer
2020
32064299
External validation of a mammographic texture marker for breast cancer risk in a case-control study.
J Med Imaging (Bellingham)
2020
32708835
Economic Evaluation of Population-Based <i>BRCA1/BRCA2</i> Mutation Testing across Multiple Countries and Health Systems.
Cancers (Basel)
2020
32226220
Risk Models for Breast Cancer and Their Validation.
Stat Sci
2020
30412281
Evaluation of a validated methylation triage signature for human papillomavirus positive women in the HPV FOCAL cervical cancer screening trial.
Int J Cancer
2019
31409912
16/18 genotyping in triage of persistent human papillomavirus infections with negative cytology in the English cervical screening pilot.
Br J Cancer
2019
31259422
The integrin αvβ6 drives pancreatic cancer through diverse mechanisms and represents an effective target for therapy.
J Pathol
2019
31423486
A Case-Control Study to Add Volumetric or Clinical Mammographic Density into the Tyrer-Cuzick Breast Cancer Risk Model.
J Breast Imaging
2019
30941651
Breast cancer pathology and stage are better predicted by risk stratification models that include mammographic density and common genetic variants.
Breast Cancer Res Treat
2019
30746393
Prediction of reader estimates of mammographic density using convolutional neural networks.
J Med Imaging (Bellingham)
2019
30452738
Competing Risks for a Diagnosis of Invasive Breast Cancer-Reply.
JAMA Oncol
2019
27920368
Use of the concordance index for predictors of censored survival data.
Stat Methods Med Res
2018
29884207
Exploring the prediction performance for breast cancer risk based on volumetric mammographic density at different thresholds.
Breast Cancer Res
2018
30180877
Novel 18-gene signature for predicting relapse in ER-positive, HER2-negative breast cancer.
Breast Cancer Res
2018
30410058
Reply to 'Comment on 'Addition of ultrasound to mammography in the case of dense breast tissue: systematic review and meta-analysis".
Br J Cancer
2018
29402289
A comparison of five methods of measuring mammographic density: a case-control study.
Breast Cancer Res
2018
29736009
Addition of ultrasound to mammography in the case of dense breast tissue: systematic review and meta-analysis.
Br J Cancer
2018
29370783
Breast cancer risk in a screening cohort of Asian and white British/Irish women from Manchester UK.
BMC Public Health
2018
29621362
Long-term Accuracy of Breast Cancer Risk Assessment Combining Classic Risk Factors and Breast Density.
JAMA Oncol
2018
29346471
Use of Single-Nucleotide Polymorphisms and Mammographic Density Plus Classic Risk Factors for Breast Cancer Risk Prediction.
JAMA Oncol
2018
29097444
RAZOR: A Phase II Open Randomized Trial of Screening Plus Goserelin and Raloxifene Versus Screening Alone in Premenopausal Women at Increased Risk of Breast Cancer.
Cancer Epidemiol Biomarkers Prev
2018
27554303
On standardized relative survival.
Biometrics
2017
34925706
The impact of using weight estimated from mammographic images <i>vs</i> self-reported weight on breast cancer risk calculation.
Proc SPIE Int Soc Opt Eng
2017
28295486
Estimating efficacy in trials with selective crossover.
Stat Med
2017
1 - 50 of 78
Column Actions
Search
Recommended Authors
Mollie E Barnard
Boston University Chobanian & Avedisian School of Medicine
Career Start Year
2011
Number of shared co-authors
0
Eric C Polley
Mayo Clinic
Career Start Year
2007
Number of shared co-authors
0
Kathryn P Lowry
University of Washington
Career Start Year
2005
Number of shared co-authors
4
Rebecca A Hubbard
Perelman School of Medicine, The University of Pennsylvania
Career Start Year
2005
Number of shared co-authors
1
Hisani N Horne
National Cancer Institute
Career Start Year
2004
Number of shared co-authors
0
Katherine D Crew
Columbia University Irving Medical Center
Career Start Year
2004
Number of shared co-authors
0
Larissa A Korde
Clinical Investigations Branch, National Cancer Institute
Career Start Year
2004
Number of shared co-authors
0
Karen J Wernli
Kaiser Permanente Washington Health Research Institute, Kaiser Permanente Washington
Career Start Year
2003
Number of shared co-authors
2
Chaya S Moskowitz
Memorial Sloan Kettering Cancer Center.
Career Start Year
2002
Number of shared co-authors
0
Clara Bodelon
National Cancer Institute, National Institute of Health, 9 Medical Center Drive
Career Start Year
2002
Number of shared co-authors
1
Peter A Fasching
Otto-Friedrich-University Bamberg
Career Start Year
2002
Number of shared co-authors
2
Fiona McKenzie
King Edward Memorial Hospital
Career Start Year
2002
Number of shared co-authors
0
Jonine D Figueroa
The Usher Institute, The University of Edinburgh
Career Start Year
2001
Number of shared co-authors
2
Aleksandra Gentry-Maharaj
UCL EGA Institute for Women's Health, University College London
Career Start Year
2000
Number of shared co-authors
2
Oscar M Rueda
University of Cambridge
Career Start Year
2000
Number of shared co-authors
1
Reina Haque
Southern California Permanente Medical Group
Career Start Year
1998
Number of shared co-authors
0
Gillian Mitchell
Familial Cancer Centre Peter MacCallum Cancer Centre Parkville Victoria 0 Australia.
Career Start Year
1998
Number of shared co-authors
1
Giovanni Parmigiani
Dana Farber Cancer Institute.
Career Start Year
1997
Number of shared co-authors
0
Paul D P Pharoah
Center for Cancer Genetic Epidemiology, University of Cambridge
Career Start Year
1994
Number of shared co-authors
6
Montserrat Garcia-Closas
National Cancer Institute
Career Start Year
1994
Number of shared co-authors
2
Abenaa M Brewster
The University of Texas MD Anderson Cancer Center
Career Start Year
1993
Number of shared co-authors
0
Sabine Behrens
German Cancer Research Center (DKFZ)
Career Start Year
1993
Number of shared co-authors
1
Usha Menon
College of Nursing, University of South Florida
Career Start Year
1991
Number of shared co-authors
3
Ruth M Pfeiffer
National Cancer Institute.
Career Start Year
1990
Number of shared co-authors
0
Hoda Anton-Culver
University of California irvine
Career Start Year
1988
Number of shared co-authors
3
Mark E Sherman
Mayo Clinic
Career Start Year
1987
Number of shared co-authors
1
Jenny Chang-Claude
German Cancer Research Center (DKFZ)
Career Start Year
1984
Number of shared co-authors
4
Donald A Berry
MD Anderson Cancer Center
Career Start Year
1980
Number of shared co-authors
0
Janet E Olson
Mayo Clinic
Career Start Year
1979
Number of shared co-authors
2
Sholom Wacholder
National Cancer Institute
Career Start Year
1977
Number of shared co-authors
1
row(s) 1 - 30 of 30
Collaborators
Simon Tiberi
University of Bologna
Co-authored papers
2
Syed Haider
Institute of Cancer Research
Co-authored papers
2
Joann G Elmore
David Geffen School of Medicine at University of California at Los Angeles
Co-authored papers
1
Daniel M Berney
Barts Cancer Institute, Queen Mary University of London
Co-authored papers
1
Liyan Xue
Xuzhou Central Hospital
Co-authored papers
1
Rupert M Pearse
William Harvey Research Institute, Queen Mary University of London
Co-authored papers
1
Pin-Chieh Wang
Co-authored papers
1
John R Prowle
Royal London Hospital, Barts Health NHS Trust
Co-authored papers
1
Christoph I Lee
University of Washington School of Medicine
Co-authored papers
1
William Hsu
American Medical Informatics Association, IEEE, Johns Hopkins University, Radiological Society of North America, University of California Los Angeles, University of California, Los Angeles
Co-authored papers
1
Rosalind A Eeles
The Institute of Cancer Research
Co-authored papers
1
Mark J Caulfield
William Harvey Research Institute, Queen Mary University of London
Co-authored papers
1
Yong-Jie Lu
Barts Cancer Institute, Queen Mary University of London
Co-authored papers
1
Christoph Thiemermann
The William Harvey Research Institute, Queen Mary University of London
Co-authored papers
1
John K Field
University of Liverpool, Molecular & Clinical Cancer Medicine
Co-authored papers
1
William Hsu
Co-authored papers
1
Fiona J Gilbert
Cambridge University
Co-authored papers
1
Anne C Hoyt
University of California los angeles
Co-authored papers
1
Arash Naeim
University of California los angeles
Co-authored papers
1
Jeremy S Paige
University of California los angeles
Co-authored papers
1
Jennifer Stone
Co-authored papers
1
Yongwei Yu
Changhai Hospital
Co-authored papers
1
1 - 22